← Eichor
Study identifier: NCT06715839 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Target-specific immunoPET Imaging of Digestive System Carcinoma

Condition: Malignancy · Digestive Cancer · Digestive System Neoplasm  ·  Sponsor: RenJi Hospital

PhaseNA
Planned participants400
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The aim of this study is to establish and optimize the target-specific PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in digestive system malignant tumors will be evaluated.

This description comes directly from the study's public registry record.

Talk to the study team

Weijun Wei, Ph.D. & M.D.  ·  15000083153  ·  wwei@shsmu.edu.cn

Shuxian An, Ph.D. & M.D.  ·  17717453484  ·  anshuxian@shsmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06715839